Key result
Elevated METTL3 and YTHDF1 expression correlates with higher platelet aggregation in low aspirin responders.
Why the study?
The role and mechanism of RNA m6A methylation in reduced antiplatelet response to aspirin in older adults remained to be explored.
Is RNA m6A methylation via the METTL3-YTHDF1-COX-1 axis associated with reduced antiplatelet response to aspirin in older adults?
Cross-Sectional (n=34)
Open-label
No
Is RNA m6A methylation via the METTL3-YTHDF1-COX-1 axis associated with reduced antiplatelet response to aspirin in older adults?
Identifies the epitranscriptomic METTL3-YTHDF1-COX-1 axis as a novel mechanistic contributor and potential biomarker for reduced antiplatelet responsiveness to aspirin in older adults.
Answers are grounded in this paper and cite their sources.
Should not alter aspirin use in older adults; hypothesis-generating for METTL3-YTHDF1 as low-response biomarker.
This study explores the role and mechanism of RNA m6A methylation in reduced antiplatelet response to aspirin in older adults. A total of 34 patients aged ≥60 years routinely receiving 100 mg/d aspirin were enrolled. Based on light transmission aggregometry (LTA), subjects were divided into a low-response group ( n = 14, platelet aggregation rate (PAR) ≥12 %) and a high-response group ( n = 20, PAR ≤7 %). Patients with a low aspirin response exhibited higher levels of m6A, accompanied by elevated methyltransferase-like 3 (METTL3) and YTH N6-methyladenosine RNA binding protein 1 (YTHDF1) ( p < 0.05). Serum levels of prostaglandin H2 (PGH2) and thromboxane B2 (TXB2) were also elevated in the low-response group. Spearman correlation revealed that PAR and PGH2 were positively correlated with both METTL3 and YTHDF1 mRNA, while TXB2 positively correlated with METTL3 mRNA ( p < 0.05), indicating the association of m6A degree with aspirin response. Mechanistically, METTL3 overexpression in MEG-01 cells enhanced megakaryocyte proliferation and upregulated YTHDF1 , which subsequently increased the translation efficiency of cyclooxygenase 1 (COX-1) mRNA and elevated COX-1 protein. RNA immunoprecipitation confirmed that YTHDF1 directly bound to COX-1 mRNA in a METTL3-dependent manner. The METTL3/ YTHDF1-COX-1 axis may attenuate the antiplatelet efficiency of aspirin by modulating AA metabolism and megakaryocyte function, providing a potential biomarker and target for aspirin low-responsiveness.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) conducted a cross-sectional in Aspirin low-responsiveness in older adults receiving primary or secondary cardiovascular prevention (n=34). Aspirin low response (PAR ≥12%) and elevated METTL3/YTHDF1 m6A methylation axis vs. Aspirin high response (PAR ≤7%) was evaluated on Whole-blood RNA m6A methylation, METTL3 and YTHDF1 mRNA expression, and correlation with platelet aggregation rate (PAR) (p=0.008). Elevated METTL3 and YTHDF1 mRNA expression positively correlated with platelet aggregation rate (rs=0.449, p=0.008 and rs=0.365, p=0.034) in older adults with low aspirin response.
Synapse has enriched 10 related papers. Consider them for comparative context: